H-LTDEMIAQY-OH

Ref. 3D-PP48056

Product Information

• Name: H-LTDEMIAQY-OH

Description

Peptide H-LTDEMIAQY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LTDEMIAQY-OH include the following: Identification of Viral and Cancer epitopes using peptide: MHC Stability measurements OA Lie-Andersen - 2022 - orbit.dtu.dkhttps://orbit.dtu.dk/en/publications/identification-of-viral-and-cancer-epitopes-using-peptidemhc-stab Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells O Lie-Andersen, ML Hubbe, K Subramaniam - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1151659/full HLA-A* 02 affinity to SARS-CoV-2 and susceptibility to COVID-19 LN Ribeiro, FS Sanches, VM Lelis - European Journal , 2023 - journals.tmkarpinski.comhttp://journals.tmkarpinski.com/index.php/ejbr/article/view/698 Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals E Galeota, V Bevilacqua, A Gobbini, P Gruarin - Clinical , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S152166162400055X Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization C Ragone, A Mauriello, B Cavalluzzo - Frontiers in , 2024 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1398002/abstract Assessing Predictive Value of SARS-CoV-2 Epitope-Specific CD8+ T-Cell Response in Patients with Severe Symptoms C Martaca­n-Martaca­n, E Salgado del Riego, JRV Castiaca±eira - Vaccines, 2024 - mdpi.comhttps://www.mdpi.com/2076-393X/12/6/679 Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination B Armistead , Y Jiang, M Carlson, ES Ford, S Jani - Mucosal , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S193302192300003X In-silico Immunomodelling of 2019-nCoV A Maali, H Teimouri, S Amiri, S Adibzadeh , M Azad - 2020 - europepmc.orghttps://europepmc.org/article/ppr/ppr153642 In-silico Immunomodelling of SARS-CoV-2 A Maali , H Teimouri , M Azad, S Amiri - Journal of Medical , 2021 - jommid.pasteur.ac.irhttp://jommid.pasteur.ac.ir/article-1-326-fa.html Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach A Alam , A Khan, N Imam, MF Siddiqui - Briefings in , 2021 - academic.oup.comhttps://academic.oup.com/bib/article-abstract/22/2/1309/6025506 Design of an epitope-based peptide vaccine against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a vaccine-informatics approach A Alam , A Khan, N Imam, MF Siddiqui, M Waseem - BioRxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.05.03.074930.abstract

• Brand: Biosynth